MedTrace Logo

Isoflurane-induced Neuroinflammation in Children With Hydrocephalus

NCT02512809 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2018-12-13

Study results available
· View outcomes & findings →

Summary

The investigators will quantify inflammatory biomarkers in cerebrospinal fluid (CSF) and serum of children with hydrocephalus who are undergoing ventriculoperitoneal shunt placement under isoflurane anesthesia.

Conditions

  • Toxicity
  • Hydrocephalus

Interventions

DRUG

Isoflurane

DRUG

Dexmedetomidine

Sponsors & Collaborators

  • Ohio State University

    collaborator OTHER

  • Nationwide Children's Hospital

    lead OTHER

Principal Investigators

  • Joseph Tobias, M.D. · Nationwide Children's Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-10-31
Completion
2017-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02512809 on ClinicalTrials.gov